The use of Design of Experiments to develop Efficient Arrays for SAR and Property Exploration

Size: px
Start display at page:

Download "The use of Design of Experiments to develop Efficient Arrays for SAR and Property Exploration"

Transcription

1 The use of Design of Experiments to develop Efficient Arrays for SAR and Property Exploration Chris Luscombe, Computational Chemistry GlaxoSmithKline

2 Summary of Talk Traditional approaches SAR Free-Wilson Design of experiments Examples Learnings Conclusions

3 Objectives of Lead Optimisation Design Array experiments to answer SAR questions to enhance potency Improve physicochemical properties Discover new monomer groups of interest. LHS O N H Core/Linker O RHS

4 How do we traditionally determine SAR array design Optimisation at a single position allows Easy synthesis planning Detailed understanding of SAR Assumes FW type additivity Substituent contributions at different positions are independent and additive This approach is widely used and very successful

5 Free Wilson theory R1-Core-R2 First mathematical technique for quantitative SAR Response = effect of Core + effect R1 substituent + effect of R2 substituent Assumptions Core makes a constant contribution All contributions are additive No interactions between core and substituent No interaction between substituents Can only explore chemical space defined by R-group combinations in the training set

6 Assessing Additivity Assumptions Assessment of Additive/Nonadditive Effects in Structure-Activity Relationships: Implications for Iterative Drug Design J. Med. Chem. 2008, 51, Yogendra Patel, Valerie J. Gillet, Trevor Howe, Joaquin Pastor, Julen Oyarzabal, and Peter Willett

7 Design of Experiments (DOE) Experimental Design approaches are well established for the optimization of multi-factor experiments, such as reaction conditions. Typically these domains utilize continuous variables such as temperature, addition rate, time etc Can these same techniques be use where each variable is categorical?

8 DOE in Medicinal Chemistry? We propose that Design of Experiments (DOE) based approaches can be applied to array scenarios where the full (e.g. M x N) array cannot be synthesized for practical reasons. By treating each monomer in the array as a categorical factor of the design, a balanced fractional ( Sparse ) array design can be generated. This novel approach can be successfully used to understand and exploit the SAR of a late stage optimisation programme

9 Example of a Sparse Array 1/3 rd fraction from an 6 x 12 array Scatter Plot Scatter Plot amine6 amine6 amine5 amine5 amine4 amine4 amine3 amine3 amine2 amine2 amine1 amine1 Phenol_ID Phenol_ID

10 Questions Is the fraction selected sufficient to explore the chemistry space? Can we adequately assess monomer potential? Can we predict the missing compounds? Is it a practical way to direct chemistry synthesis? Is it an efficient process? Does it work?

11 Sparse Array :What are the key steps? Monomers Identify/ select which monomers to incorporate into the design Design Create an experimental design template appropriate to the investigational space define from the monomer numbers Optimise Allocate monomers into the design so define which compounds to actually synthesize Analyse Measure assay endpoints and build free-wilson models to understand the SAR

12 Monomer Selection Identify appropriate monomers at each position Use diversity, physico-chemical, ADME and scientific rationale to reduce the monomer lists Calculate the average desirability score from each monomer across the whole virtual library. Select the higher scoring ones to be included in the Final DOE array design landscape A9 A8 A7 A6 A5 A4 A3 A24 A23 A22 A21 A20 A2 A19 A18 A17 A16 A15 A14 A13 A12 A11 A10 A1 amines Mean_NR profile_by_amine B9 B8 B7 B6 B5 B4 B3 B22 B21 B20 B2 B19 B18 B17 B16 B15 B14 B13 B12 B11 B10 B1 nr score aldehydes Mean_NR profile_by_aldehyde NR profile Binned NR profile

13 Sparse Array :What are the key steps? Monomers Identify/ select which monomers to incorporate into the design Design Create an experimental design template define from the monomer numbers Optimise Allocate monomers into the design so define which compounds to synthesize Analyse Measure assay endpoints and build free-wilson models to understand the SAR

14 Design Creation (Sparse arrays) Create an in-complete balanced D-Optimal design Even numbers of monomers at each R position D Optimality Force balance Scatter Plot Level 9 of A Level 8 of A Level 7 of A Level 6 of A Level 5 of A Level 4 of A Level 3 of A Level 2 of A Level 12 of A Level 11 of A Level 10 of A Many software packages around which can generate these types of Experimental Design Level 1 of A Level 1 of B Level 2 of B Level 3 of B Level 4 of B Level 5 of B Level 6 of B Amine ID

15 Sparse Array :What are the key steps? Monomers Identify/ select which monomers to incorporate into the design Design Create an experimental design template appropriate to the investigational space define from the monomer numbers Optimise Allocate monomers into the design to define which compounds to actually synthesize Analyse Measure assay endpoints and build free-wilson models to understand the SAR

16 Which Monomer at which Position? Scatter Plot Level 9 of A Level 8 of A Level 7 of A Level 6 of A Level 5 of A Level 4 of A Level 3 of A Level 2 of A Level 12 of A Level 11 of A Level 10 of A Level 1 of A In principle monomers could be allocated in any order, including random, into the DOE array GSK use an in-house algorithmic approach to allocate monomers into the define positions in the DOE array so as to optimise the compounds to be synthesized against another property Eg diversity, lead-likeness, logp etc Level 1 of B Level 2 of B Level 3 of B Level 4 of B Level 5 of B Level 6 of B Amine ID Compounds A:Phenols B:Amines 1 Phenol 3 Amine 2 2 Phenol 6 Amine 6 3 Phenol 7 Amine 5 4 Phenol 3 Amine 3 5 Phenol 9 Amine 5 6 Phenol 6 Amine 1 7 Phenol 10 Amine 4 8 Phenol 10 Amine 2 9 Phenol 8 Amine 4 10 Phenol 5 Amine 3 11 Phenol 4 Amine 6 12 Phenol 5 Amine 1 13 Phenol 1 Amine 1 14 Phenol 11 Amine 5 15 Phenol 12 Amine 2 16 Phenol 12 Amine 6 17 Phenol 1 Amine 5 18 Phenol 8 Amine 3 19 Phenol 7 Amine 4 20 Phenol 11 Amine 6 21 Phenol 2 Amine 1 22 Phenol 9 Amine 3 23 Phenol 4 Amine 2 24 Phenol 2 Amine 4

17 Sparse Array :What are the key steps? Monomers Identify/ select which monomers to incorporate into the design Design Create an experimental design template appropriate to the investigational space define from the monomer numbers Optimise Allocate monomers into the design so define which compounds to actually synthesize Analyse Measure assay endpoints and build free- Wilson models to understand the SAR

18 Predicted FW analysis of monomer contribution A Free Wilson analysis is a regression based approach Design-Expert to Software GTPgS_CCR4_pIC50 establish monomer contributions to a predictive model Color points by value of GTPgS_CCR4_pIC50: 7.7 A high degree of fit suggests 5.5 that the potency profile could be additive in nature. The presence of outliers may imply non-additive behaviour Assess potential interaction terms between monomers if the output appears to be non-additive Predicted vs. Actual Actual

19 Example 1 Sparse array to evaluate defined N x M combinatorial space with a fractional subset Design 12 Indazoles (R1) Identified using classical SAR approaches Scatter Plot 48 sulphonyl chlorides monomers (R2) selected from library using a variety of criteria Lead-likeness score R2 Indazoles R1 12 monomers per R1 3 monomers per R2

20 Measured Potency for the Sparse array 142 of 144 compounds from patchwork array were synthesised and tested Coloured for potency, sized by ligand efficiency Clear that some Indazoles are more promising than others Array Indazole R1

21 Predicted potency from FW model Sparse Array Data Analysis Scatter Plot (2) 7.5 Statistical analysis was done to evaluate additivity Free Wilson model: Predicted potencies were plotted against measured potencies The FW model show potential excellent additivity with no outliers FW-Fit:RG-All:mol8_GR203498:GTPgS_CCR4_Human_Antagonist_pic50_Value (1) Measured potency

22 Predicted Potency for the complete array of 576 compounds (Fit and Predict), only Actives (pic50>6.5 shown) Array RG-R2 (48 Variants) Indazole R1 RG-R1 (12 Variants)

23 Find the predicted most potent compounds that haven t already been synthesized Array C1 C2 C3 C4 RG-R2 (48 variants) C5 C6 C7 Indazole R1 RG-R1 (12 variants)

24 Predicted potent compounds All compounds subsequently synthesized had measured potencies within +/- 0.2 pic50 of the predicted value Validated the Additivity assumption Identified promising alternatives which were sent for further PK analysis potential back up to the current pre-candidate C1 Predicted GTPgS = 7.6 BEI = 16.0 Measured = 7.6 C4 Predicted GTPgS = 7.5 BEI = 14.2 Measured = 7.4 C2 Predicted GTPgS = 7.5 BEI = 13.5 Measured = 7.6 C5 Predicted GTPgS = 7.6 BEI = 15.6 Measured = 7.5 C3 Predicted GTPgS = 7.5 BEI = 14.8 Measured = 7.3

25 CAT friendly example Sparse Array Automation CAT : Automated array chemistry system A particular design (nicknamed the Tetris array) which is array automation friendly and thus allows these investigational approaches to be carried out efficiently from a synthetic perspective.

26 Exploration of Chemical space coverage for a Dual targetting programme R4 monomers (96) Scatter Plot [4*]Cc1cccnc1 [4*]Cc1ccc(Cl)cc1 Status of exploration [4*]CCn1cccn1 [4*]CCc1ccccc1OCC [4*]CCc1c[nH]c(n1)C(C)C [4*]CCN1CCOCC1 [4*]CCCOC [4*]CCC [4*]CC(=C)C [4*]C(CCO)C1CC1 [4*]C(C)C1(C)CC1 [4*]C R6 RG-R6 monomers (67) 32 R4 and 12 R6 monomers were chosen for inclusion in Sparse array

27 R4 Monomers CAT friendly 8 (from 32) x 12 Tetris Array The experimental design chosen is a 8 x12 chosen from a potential 32 x 12 fully enumerated array (384 potential compounds). (¼ fraction) Level 9 of A Level 8 of A Level 7 of A Level 6 of A Level 5 of A Level 4 of A Level 32 of A Level 31 of A Level 30 of A Level 3 of A Level 29 of A Level 28 of A Level 27 of A Level 26 of A Level 25 of A Level 24 of A Level 23 of A Level 22 of A Level 21 of A Level 20 of A Level 2 of A Level 19 of A Level 18 of A Level 17 of A Level 16 of A Level 15 of A Level 14 of A Level 13 of A Level 12 of A Level 11 of A Level 10 of A Level 1 of A Scatter Plot (2) Each coloured block represents one of the 32 R4 monomers Each R4 monomer is used 3 times Each R6 monomer is used 12 times Factor Bar Chart 2 (2) Factor 2 R6 Monomers

28 Sparse array results R6 bar Using the CAT the synthesis was done efficiently and effectively Synthesis was actually done using 8 linear (1x12) arrays For the Sparse array synthesis of 77 of the 96 compounds was achieved and the compounds delivered to screening. This is approximately 75% of full sparse array Only 20% of the fully enumerated array 1 0 B94 B93 B92 B91 B9 B88 B87 B80 B76 B73 B70 B66 B63 B61 B60 B58 B57 B56 B55 B54 B46 B44 B41 B40 B39 B37 B35 B34 B33 B16 B13 B11 C15 C18 C21 C23 C30 C36 C39 C53 C54 C57 C60 C66 RG_R6 Code design C15 C18 C21 C23 C30 C36 C39 C53 C54 C57 C60 C66 RG_R6 Code

29 Monomer contribution The Programme team concluded that the chemistry within this area of chemical space was well understood wrt target potency R4 Coeff bar B11 B16 B34 B37 B40 B44 B54 B56 B58 B61 B66 B73 B80 B88 B91 B93 RG_R4 Code The Programme team predicted potent analogues with targetted physchem profiles for synthesis R6 coeff bar C15 C18 C21 C23 C30 C36 C39 C53 C54 C57 C60 C66 RG_R6 Code

30 Orthogonal dual assay Further Developments Dual target The monomers chosen in the array were selected to create Primary actives but were not thought likely to have any potential in Secondary target assay However, surprisingly 14 compounds were found to be active in the second assay Currently being followed up in the programme team as potential dual antagonists FW (2) Further analogue expansion around this monomer C15 C18 C21 C23 C30 C36 C39 C53 C54 C57 C60 C66 RG_R6 Code Sized by Primary potency coloured by R4 group

31 EXAMPLE 3 EXTENDED 3 RG TETRIS SPARSE ARRAY 3 points of change on the molecule Acids O N H Core O Phenols

32 Extended 3 RG Tetris Sparse array Cores (A) = 3 (These were used to explore a stereo chemistry question) Phenols (B) = 4 Acids (C) = 24 All acids represented 3 times 3x4x24 = 288 compounds 25% of full array synthesised Distribution balanced Extended TETRIS array Coloured by Acid monomer group

33 OTHER DESIGN TYPES Latin Squares: Symmetrical design spaces Useful for n x n x n problems where n = number of monomers in each RG position Eg 6 R1 x 6 R2 x 6 R3 A 1/n fraction is selected R2 N R1 R3

34 Three RG positions Latin Squares Predictive Array Design: LIPKIN, ROSE,SAR and QSAR in Environmental Research, 2002 Vol 13 (3-4) pp Scatter Plot Pie Chart B6 B5 B4 B3 B2 B1 A1 A2 A3 A4 A5 A6 Factor 1 Each possible pair of monomers is present once and that each monomer is present an equal number of times defined by the array dimensions.

35 Pros and Cons of Sparse array approaches Objective exploration generates an optimal data set for ANOVA / Free-Wilson analysis. Chemistry may be more difficult to carry-out Complete evaluation of potency response within the design space from only a fraction of the possible compounds Needs a reasonable resource commitment upfront Defined endpoint to the work Needs majority of compounds chosen in the array to be made and measured for the analysis to be robust Excellent data set for QSAR Assumes Additivity (but then so does Linear SAR exploration)

36 Learnings from experience Ideally 3 examples minimum for each monomer within the design, although 2 will work for a robust assay and chemistry Need to have confidence in getting some active compounds If all the compounds are inactive its difficult to fit a model! Confidence in ability to synthesize compounds Some loss of particular compounds can be tolerated but if whole reactions fail then the array design will be compromised

37 Summary Experimental Design may provide an alternative /complementary strategy which may be suitable in some circumstances E.g. Initial exploration of new monomer space Identification of back up compounds Establish Addivity in the series Efficient Lead Optimisation by exploring more than one point of change at the same time on the molecular template Can unearth some surprises which may never have been found by traditional processes There are different design types for different situations Software is available to create the designs Work well in situations where the bespoke synthesis is contracted out

38 Acknowledgements Tony Cooper Heather Hobbs Medicinal Chemistry Nick Barton Stephen Pickett Darren Green Computational Chemistry

39 References to literature to date How design Concepts can Improve Experimentation: Mager 1997 Use of iterative search techniques to find monomers which have the required levels of particular physico chemical properties to fit into an ideal experimental design Statistical Molecular Design of BB for CombiChem: Linusson, Wold etal 1999 Selection of BB s using t- scores of the enumerated library as variables and then applying D-Optimal, Space Filling or Cluster based selection strategies Predictive Array Design: LIPKIN, ROSE etal, 2002 Use of Latin Squares Simulated Annealing for Monomer assignment

Hit Finding and Optimization Using BLAZE & FORGE

Hit Finding and Optimization Using BLAZE & FORGE Hit Finding and Optimization Using BLAZE & FORGE Kevin Cusack,* Maria Argiriadi, Eric Breinlinger, Jeremy Edmunds, Michael Hoemann, Michael Friedman, Sami Osman, Raymond Huntley, Thomas Vargo AbbVie, Immunology

More information

Bioisosteres in Medicinal Chemistry

Bioisosteres in Medicinal Chemistry Edited by Nathan Brown Bioisosteres in Medicinal Chemistry VCH Verlag GmbH & Co. KGaA Contents List of Contributors Preface XV A Personal Foreword XI XVII Part One Principles 1 Bioisosterism in Medicinal

More information

AMRI COMPOUND LIBRARY CONSORTIUM: A NOVEL WAY TO FILL YOUR DRUG PIPELINE

AMRI COMPOUND LIBRARY CONSORTIUM: A NOVEL WAY TO FILL YOUR DRUG PIPELINE AMRI COMPOUD LIBRARY COSORTIUM: A OVEL WAY TO FILL YOUR DRUG PIPELIE Muralikrishna Valluri, PhD & Douglas B. Kitchen, PhD Summary The creation of high-quality, innovative small molecule leads is a continual

More information

EMPIRICAL VS. RATIONAL METHODS OF DISCOVERING NEW DRUGS

EMPIRICAL VS. RATIONAL METHODS OF DISCOVERING NEW DRUGS EMPIRICAL VS. RATIONAL METHODS OF DISCOVERING NEW DRUGS PETER GUND Pharmacopeia Inc., CN 5350 Princeton, NJ 08543, USA pgund@pharmacop.com Empirical and theoretical approaches to drug discovery have often

More information

PROVIDING CHEMINFORMATICS SOLUTIONS TO SUPPORT DRUG DISCOVERY DECISIONS

PROVIDING CHEMINFORMATICS SOLUTIONS TO SUPPORT DRUG DISCOVERY DECISIONS 179 Molecular Informatics: Confronting Complexity, May 13 th - 16 th 2002, Bozen, Italy PROVIDING CHEMINFORMATICS SOLUTIONS TO SUPPORT DRUG DISCOVERY DECISIONS CARLETON R. SAGE, KEVIN R. HOLME, NIANISH

More information

Medicinal Chemist s Relationship with Additivity: Are we Taking the Fundamentals for Granted?

Medicinal Chemist s Relationship with Additivity: Are we Taking the Fundamentals for Granted? Medicinal Chemist s Relationship with Additivity: Are we Taking the Fundamentals for Granted? J. Guy Breitenbucher Streamlining Drug Discovery Conference San Francisco, CA ct. 25, 2018 Additivity as the

More information

Use of data mining and chemoinformatics in the identification and optimization of high-throughput screening hits for NTDs

Use of data mining and chemoinformatics in the identification and optimization of high-throughput screening hits for NTDs Use of data mining and chemoinformatics in the identification and optimization of high-throughput screening hits for NTDs James Mills; Karl Gibson, Gavin Whitlock, Paul Glossop, Jean-Robert Ioset, Leela

More information

Bridging the Dimensions:

Bridging the Dimensions: Bridging the Dimensions: Seamless Integration of 3D Structure-based Design and 2D Structure-activity Relationships to Guide Medicinal Chemistry ACS Spring National Meeting. COMP, March 13 th 2016 Marcus

More information

Exploring the chemical space of screening results

Exploring the chemical space of screening results Exploring the chemical space of screening results Edmund Champness, Matthew Segall, Chris Leeding, James Chisholm, Iskander Yusof, Nick Foster, Hector Martinez ACS Spring 2013, 7 th April 2013 Optibrium,

More information

Building innovative drug discovery alliances. Just in KNIME: Successful Process Driven Drug Discovery

Building innovative drug discovery alliances. Just in KNIME: Successful Process Driven Drug Discovery Building innovative drug discovery alliances Just in KIME: Successful Process Driven Drug Discovery Berlin KIME Spring Summit, Feb 2016 Research Informatics @ Evotec Evotec s worldwide operations 2 Pharmaceuticals

More information

Practical QSAR and Library Design: Advanced tools for research teams

Practical QSAR and Library Design: Advanced tools for research teams DS QSAR and Library Design Webinar Practical QSAR and Library Design: Advanced tools for research teams Reservationless-Plus Dial-In Number (US): (866) 519-8942 Reservationless-Plus International Dial-In

More information

Computational Methods and Drug-Likeness. Benjamin Georgi und Philip Groth Pharmakokinetik WS 2003/2004

Computational Methods and Drug-Likeness. Benjamin Georgi und Philip Groth Pharmakokinetik WS 2003/2004 Computational Methods and Drug-Likeness Benjamin Georgi und Philip Groth Pharmakokinetik WS 2003/2004 The Problem Drug development in pharmaceutical industry: >8-12 years time ~$800m costs >90% failure

More information

Automated Compound Collection Enhancement: how Pipeline Pilot preserved our sanity. Darren Green GSK

Automated Compound Collection Enhancement: how Pipeline Pilot preserved our sanity. Darren Green GSK Automated Compound Collection Enhancement: how Pipeline Pilot preserved our sanity Darren Green GSK The Compound Collection Enhancement Challenge A diversity of ideas Which are novel Which have the desired

More information

De Novo molecular design with Deep Reinforcement Learning

De Novo molecular design with Deep Reinforcement Learning De Novo molecular design with Deep Reinforcement Learning @olexandr Olexandr Isayev, Ph.D. University of North Carolina at Chapel Hill olexandr@unc.edu http://olexandrisayev.com About me Ph.D. in Chemistry

More information

Web tools for Monomer selection, Library Design and Compound Acquisition. Andrew Leach GlaxoSmithKline Research and Development Stevenage

Web tools for Monomer selection, Library Design and Compound Acquisition. Andrew Leach GlaxoSmithKline Research and Development Stevenage Web tools for Monomer selection, Library Design and Compound Acquisition Andrew Leach GlaxoSmithKline Research and Development Stevenage Historical perspective Bench scientists unused to dealing with and

More information

Introduction. OntoChem

Introduction. OntoChem Introduction ntochem Providing drug discovery knowledge & small molecules... Supporting the task of medicinal chemistry Allows selecting best possible small molecule starting point From target to leads

More information

Applying Bioisosteric Transformations to Predict Novel, High Quality Compounds

Applying Bioisosteric Transformations to Predict Novel, High Quality Compounds Applying Bioisosteric Transformations to Predict Novel, High Quality Compounds Dr James Chisholm,* Dr John Barnard, Dr Julian Hayward, Dr Matthew Segall*, Mr Edmund Champness*, Dr Chris Leeding,* Mr Hector

More information

Interactive Feature Selection with

Interactive Feature Selection with Chapter 6 Interactive Feature Selection with TotalBoost g ν We saw in the experimental section that the generalization performance of the corrective and totally corrective boosting algorithms is comparable.

More information

Early Stages of Drug Discovery in the Pharmaceutical Industry

Early Stages of Drug Discovery in the Pharmaceutical Industry Early Stages of Drug Discovery in the Pharmaceutical Industry Daniel Seeliger / Jan Kriegl, Discovery Research, Boehringer Ingelheim September 29, 2016 Historical Drug Discovery From Accidential Discovery

More information

COMBINATORIAL CHEMISTRY IN A HISTORICAL PERSPECTIVE

COMBINATORIAL CHEMISTRY IN A HISTORICAL PERSPECTIVE NUE FEATURE T R A N S F O R M I N G C H A L L E N G E S I N T O M E D I C I N E Nuevolution Feature no. 1 October 2015 Technical Information COMBINATORIAL CHEMISTRY IN A HISTORICAL PERSPECTIVE A PROMISING

More information

Computational chemical biology to address non-traditional drug targets. John Karanicolas

Computational chemical biology to address non-traditional drug targets. John Karanicolas Computational chemical biology to address non-traditional drug targets John Karanicolas Our computational toolbox Structure-based approaches Ligand-based approaches Detailed MD simulations 2D fingerprints

More information

Advanced Medicinal Chemistry SLIDES B

Advanced Medicinal Chemistry SLIDES B Advanced Medicinal Chemistry Filippo Minutolo CFU 3 (21 hours) SLIDES B Drug likeness - ADME two contradictory physico-chemical parameters to balance: 1) aqueous solubility 2) lipid membrane permeability

More information

Cheminformatics Role in Pharmaceutical Industry. Randal Chen Ph.D. Abbott Laboratories Aug. 23, 2004 ACS

Cheminformatics Role in Pharmaceutical Industry. Randal Chen Ph.D. Abbott Laboratories Aug. 23, 2004 ACS Cheminformatics Role in Pharmaceutical Industry Randal Chen Ph.D. Abbott Laboratories Aug. 23, 2004 ACS Agenda The big picture for pharmaceutical industry Current technological/scientific issues Types

More information

OECD QSAR Toolbox v.3.0

OECD QSAR Toolbox v.3.0 OECD QSAR Toolbox v.3.0 Step-by-step example of how to categorize an inventory by mechanistic behaviour of the chemicals which it consists Background Objectives Specific Aims Trend analysis The exercise

More information

Design Drugs Collaboratively Using Spotfire Visualization and Analysis

Design Drugs Collaboratively Using Spotfire Visualization and Analysis Design Drugs Collaboratively Using Spotfire Visualization and Analysis Anthony Donofrio PKI Data Analysis & R&D Informatics East Coast User Conference GSK Upper Merion, PA 09/15/2016 Merck Research Laboratories

More information

Integrated Cheminformatics to Guide Drug Discovery

Integrated Cheminformatics to Guide Drug Discovery Integrated Cheminformatics to Guide Drug Discovery Matthew Segall, Ed Champness, Peter Hunt, Tamsin Mansley CINF Drug Discovery Cheminformatics Approaches August 23 rd 2017 Optibrium, StarDrop, Auto-Modeller,

More information

OECD QSAR Toolbox v.3.3. Step-by-step example of how to categorize an inventory by mechanistic behaviour of the chemicals which it consists

OECD QSAR Toolbox v.3.3. Step-by-step example of how to categorize an inventory by mechanistic behaviour of the chemicals which it consists OECD QSAR Toolbox v.3.3 Step-by-step example of how to categorize an inventory by mechanistic behaviour of the chemicals which it consists Background Objectives Specific Aims Trend analysis The exercise

More information

Important Aspects of Fragment Screening Collection Design

Important Aspects of Fragment Screening Collection Design Important Aspects of Fragment Screening Collection Design Phil Cox, Ph. D., Discovery Chemistry and Technology, AbbVie, USA Cresset User Group Meeting, Cambridge UK. Thursday, June 29 th 2017 Disclosure-

More information

Notes of Dr. Anil Mishra at 1

Notes of Dr. Anil Mishra at   1 Introduction Quantitative Structure-Activity Relationships QSPR Quantitative Structure-Property Relationships What is? is a mathematical relationship between a biological activity of a molecular system

More information

QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression

QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression APPLICATION NOTE QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression GAINING EFFICIENCY IN QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIPS ErbB1 kinase is the cell-surface receptor

More information

An Integrated Approach to in-silico

An Integrated Approach to in-silico An Integrated Approach to in-silico Screening Joseph L. Durant Jr., Douglas. R. Henry, Maurizio Bronzetti, and David. A. Evans MDL Information Systems, Inc. 14600 Catalina St., San Leandro, CA 94577 Goals

More information

Biologically Relevant Molecular Comparisons. Mark Mackey

Biologically Relevant Molecular Comparisons. Mark Mackey Biologically Relevant Molecular Comparisons Mark Mackey Agenda > Cresset Technology > Cresset Products > FieldStere > FieldScreen > FieldAlign > FieldTemplater > Cresset and Knime About Cresset > Specialist

More information

CHAPTER 6 QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP (QSAR) ANALYSIS

CHAPTER 6 QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP (QSAR) ANALYSIS 159 CHAPTER 6 QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP (QSAR) ANALYSIS 6.1 INTRODUCTION The purpose of this study is to gain on insight into structural features related the anticancer, antioxidant

More information

Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME

Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME Iván Solt Solutions for Cheminformatics Drug Discovery Strategies for known targets High-Throughput Screening (HTS) Cells

More information

In Silico Investigation of Off-Target Effects

In Silico Investigation of Off-Target Effects PHARMA & LIFE SCIENCES WHITEPAPER In Silico Investigation of Off-Target Effects STREAMLINING IN SILICO PROFILING In silico techniques require exhaustive data and sophisticated, well-structured informatics

More information

Capturing Chemistry. What you see is what you get In the world of mechanism and chemical transformations

Capturing Chemistry. What you see is what you get In the world of mechanism and chemical transformations Capturing Chemistry What you see is what you get In the world of mechanism and chemical transformations Dr. Stephan Schürer ead of Intl. Sci. Content Libraria, Inc. sschurer@libraria.com Distribution of

More information

COMBINATORIAL CHEMISTRY: CURRENT APPROACH

COMBINATORIAL CHEMISTRY: CURRENT APPROACH COMBINATORIAL CHEMISTRY: CURRENT APPROACH Dwivedi A. 1, Sitoke A. 2, Joshi V. 3, Akhtar A.K. 4* and Chaturvedi M. 1, NRI Institute of Pharmaceutical Sciences, Bhopal, M.P.-India 2, SRM College of Pharmacy,

More information

Statistical concepts in QSAR.

Statistical concepts in QSAR. Statistical concepts in QSAR. Computational chemistry represents molecular structures as a numerical models and simulates their behavior with the equations of quantum and classical physics. Available programs

More information

The Institute of Cancer Research PHD STUDENTSHIP PROJECT PROPOSAL

The Institute of Cancer Research PHD STUDENTSHIP PROJECT PROPOSAL The Institute of Cancer Research PHD STUDENTSHIP PROJECT PROPOSAL PROJECT DETAILS Project Title: Design and synthesis of libraries of bifunctional degraders for the discovery of new cancer targets SUPERVISORY

More information

MOLECULAR DIVERSITY IN DRUG DESIGN

MOLECULAR DIVERSITY IN DRUG DESIGN MOLECULAR DIVERSITY IN DRUG DESIGN MOLECULAR DIVERSITY IN DRUG DESIGN Edited by PHILIP M. DEAN and RICHARD A. LEWIS KLUWER ACADEMIC PUBLISHERS NEW YORK / BOSTON / DORDRECHT / LONDON / MOSCOW ebook ISBN:

More information

Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation

Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation Charles Blundell charles.blundell@c4xdiscovery.com www.c4xdiscovery.com Rigid: single

More information

Analysis of a Large Structure/Biological Activity. Data Set Using Recursive Partitioning and. Simulated Annealing

Analysis of a Large Structure/Biological Activity. Data Set Using Recursive Partitioning and. Simulated Annealing Analysis of a Large Structure/Biological Activity Data Set Using Recursive Partitioning and Simulated Annealing Student: Ke Zhang MBMA Committee: Dr. Charles E. Smith (Chair) Dr. Jacqueline M. Hughes-Oliver

More information

QSAR/QSPR modeling. Quantitative Structure-Activity Relationships Quantitative Structure-Property-Relationships

QSAR/QSPR modeling. Quantitative Structure-Activity Relationships Quantitative Structure-Property-Relationships Quantitative Structure-Activity Relationships Quantitative Structure-Property-Relationships QSAR/QSPR modeling Alexandre Varnek Faculté de Chimie, ULP, Strasbourg, FRANCE QSAR/QSPR models Development Validation

More information

DivCalc: A Utility for Diversity Analysis and Compound Sampling

DivCalc: A Utility for Diversity Analysis and Compound Sampling Molecules 2002, 7, 657-661 molecules ISSN 1420-3049 http://www.mdpi.org DivCalc: A Utility for Diversity Analysis and Compound Sampling Rajeev Gangal* SciNova Informatics, 161 Madhumanjiri Apartments,

More information

Translating Methods from Pharma to Flavours & Fragrances

Translating Methods from Pharma to Flavours & Fragrances Translating Methods from Pharma to Flavours & Fragrances CINF 27: ACS National Meeting, New Orleans, LA - 18 th March 2018 Peter Hunt, Edmund Champness, Nicholas Foster, Tamsin Mansley & Matthew Segall

More information

Next Generation Computational Chemistry Tools to Predict Toxicity of CWAs

Next Generation Computational Chemistry Tools to Predict Toxicity of CWAs Next Generation Computational Chemistry Tools to Predict Toxicity of CWAs William (Bill) Welsh welshwj@umdnj.edu Prospective Funding by DTRA/JSTO-CBD CBIS Conference 1 A State-wide, Regional and National

More information

György M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences

György M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences Fragment based lead discovery - introduction György M. Keserű H2020 FRAGET etwork Hungarian Academy of Sciences www.fragnet.eu Hit discovery from screening Druglike library Fragment library Large molecules

More information

Quantum Mechanical Models of P450 Metabolism to Guide Optimization of Metabolic Stability

Quantum Mechanical Models of P450 Metabolism to Guide Optimization of Metabolic Stability Quantum Mechanical Models of P450 Metabolism to Guide Optimization of Metabolic Stability Optibrium Webinar 2015, June 17 2015 Jonathan Tyzack, Matthew Segall, Peter Hunt Optibrium, StarDrop, Auto-Modeller

More information

Chemical library design

Chemical library design Chemical library design Pavel Polishchuk Institute of Molecular and Translational Medicine Palacky University pavlo.polishchuk@upol.cz Drug development workflow Vistoli G., et al., Drug Discovery Today,

More information

OECD QSAR Toolbox v.3.3

OECD QSAR Toolbox v.3.3 OECD QSAR Toolbox v.3.3 Step-by-step example on how to predict the skin sensitisation potential of a chemical by read-across based on an analogue approach Outlook Background Objectives Specific Aims Read

More information

OECD QSAR Toolbox v.3.3. Predicting skin sensitisation potential of a chemical using skin sensitization data extracted from ECHA CHEM database

OECD QSAR Toolbox v.3.3. Predicting skin sensitisation potential of a chemical using skin sensitization data extracted from ECHA CHEM database OECD QSAR Toolbox v.3.3 Predicting skin sensitisation potential of a chemical using skin sensitization data extracted from ECHA CHEM database Outlook Background The exercise Workflow Save prediction 23.02.2015

More information

Virtual Screening: How Are We Doing?

Virtual Screening: How Are We Doing? Virtual Screening: How Are We Doing? Mark E. Snow, James Dunbar, Lakshmi Narasimhan, Jack A. Bikker, Dan Ortwine, Christopher Whitehead, Yiannis Kaznessis, Dave Moreland, Christine Humblet Pfizer Global

More information

Design and Synthesis of the Comprehensive Fragment Library

Design and Synthesis of the Comprehensive Fragment Library YOUR INNOVATIVE CHEMISTRY PARTNER IN DRUG DISCOVERY Design and Synthesis of the Comprehensive Fragment Library A 3D Enabled Library for Medicinal Chemistry Discovery Warren S Wade 1, Kuei-Lin Chang 1,

More information

OECD QSAR Toolbox v.3.4

OECD QSAR Toolbox v.3.4 OECD QSAR Toolbox v.3.4 Step-by-step example on how to predict the skin sensitisation potential approach of a chemical by read-across based on an analogue approach Outlook Background Objectives Specific

More information

Kinome-wide Activity Models from Diverse High-Quality Datasets

Kinome-wide Activity Models from Diverse High-Quality Datasets Kinome-wide Activity Models from Diverse High-Quality Datasets Stephan C. Schürer*,1 and Steven M. Muskal 2 1 Department of Molecular and Cellular Pharmacology, Miller School of Medicine and Center for

More information

Situation. The XPS project. PSO publication pattern. Problem. Aims. Areas

Situation. The XPS project. PSO publication pattern. Problem. Aims. Areas Situation The XPS project we are looking at a paradigm in its youth, full of potential and fertile with new ideas and new perspectives Researchers in many countries are experimenting with particle swarms

More information

Overview. Descriptors. Definition. Descriptors. Overview 2D-QSAR. Number Vector Function. Physicochemical property (log P) Atom

Overview. Descriptors. Definition. Descriptors. Overview 2D-QSAR. Number Vector Function. Physicochemical property (log P) Atom verview D-QSAR Definition Examples Features counts Topological indices D fingerprints and fragment counts R-group descriptors ow good are D descriptors in practice? Summary Peter Gedeck ovartis Institutes

More information

Receptor Based Drug Design (1)

Receptor Based Drug Design (1) Induced Fit Model For more than 100 years, the behaviour of enzymes had been explained by the "lock-and-key" mechanism developed by pioneering German chemist Emil Fischer. Fischer thought that the chemicals

More information

MSc Drug Design. Module Structure: (15 credits each) Lectures and Tutorials Assessment: 50% coursework, 50% unseen examination.

MSc Drug Design. Module Structure: (15 credits each) Lectures and Tutorials Assessment: 50% coursework, 50% unseen examination. Module Structure: (15 credits each) Lectures and Assessment: 50% coursework, 50% unseen examination. Module Title Module 1: Bioinformatics and structural biology as applied to drug design MEDC0075 In the

More information

Enamine Golden Fragment Library

Enamine Golden Fragment Library Enamine Golden Fragment Library 14 March 216 1794 compounds deliverable as entire set or as selected items. Fragment Based Drug Discovery (FBDD) [1,2] demonstrates remarkable results: more than 3 compounds

More information

Using AutoDock for Virtual Screening

Using AutoDock for Virtual Screening Using AutoDock for Virtual Screening CUHK Croucher ASI Workshop 2011 Stefano Forli, PhD Prof. Arthur J. Olson, Ph.D Molecular Graphics Lab Screening and Virtual Screening The ultimate tool for identifying

More information

Medicinal Chemistry/ CHEM 458/658 Chapter 3- SAR and QSAR

Medicinal Chemistry/ CHEM 458/658 Chapter 3- SAR and QSAR Medicinal Chemistry/ CHEM 458/658 Chapter 3- SAR and QSAR Bela Torok Department of Chemistry University of Massachusetts Boston Boston, MA 1 Introduction Structure-Activity Relationship (SAR) - similar

More information

Reaxys Medicinal Chemistry Fact Sheet

Reaxys Medicinal Chemistry Fact Sheet R&D SOLUTIONS FOR PHARMA & LIFE SCIENCES Reaxys Medicinal Chemistry Fact Sheet Essential data for lead identification and optimization Reaxys Medicinal Chemistry empowers early discovery in drug development

More information

Molecular Dynamics Graphical Visualization 3-D QSAR Pharmacophore QSAR, COMBINE, Scoring Functions, Homology Modeling,..

Molecular Dynamics Graphical Visualization 3-D QSAR Pharmacophore QSAR, COMBINE, Scoring Functions, Homology Modeling,.. 3 Conformational Search Molecular Docking Simulate Annealing Ab Initio QM Molecular Dynamics Graphical Visualization 3-D QSAR Pharmacophore QSAR, COMBINE, Scoring Functions, Homology Modeling,.. Rino Ragno:

More information

In silico pharmacology for drug discovery

In silico pharmacology for drug discovery In silico pharmacology for drug discovery In silico drug design In silico methods can contribute to drug targets identification through application of bionformatics tools. Currently, the application of

More information

Keywords: anti-coagulants, factor Xa, QSAR, Thrombosis. Introduction

Keywords: anti-coagulants, factor Xa, QSAR, Thrombosis. Introduction PostDoc Journal Vol. 2, No. 3, March 2014 Journal of Postdoctoral Research www.postdocjournal.com QSAR Study of Thiophene-Anthranilamides Based Factor Xa Direct Inhibitors Preetpal S. Sidhu Department

More information

Lecture for Molekylär bioinformatik X3 Feb Computational Chemistry in Drug Discovery. Mats Kihlén. Head of Research Informatics.

Lecture for Molekylär bioinformatik X3 Feb Computational Chemistry in Drug Discovery. Mats Kihlén. Head of Research Informatics. Lecture for Molekylär bioinformatik X3 Feb 24 2004 Computational Chemistry in Drug Discovery Mats Kihlén Head of Research Informatics Biovitrum AB verview» The role of computational chemistry» Basic concepts

More information

Synthetic organic compounds

Synthetic organic compounds Synthetic organic compounds for research and drug discovery Compounds for TS Fragment libraries Target-focused libraries Chemical building blocks Custom synthesis Drug discovery services Contract research

More information

Sensitivity Analysis with Correlated Variables

Sensitivity Analysis with Correlated Variables Sensitivity Analysis with Correlated Variables st Workshop on Nonlinear Analysis of Shell Structures INTALES GmbH Engineering Solutions University of Innsbruck, Faculty of Civil Engineering University

More information

Unlocking the potential of your drug discovery programme

Unlocking the potential of your drug discovery programme Unlocking the potential of your drug discovery programme Innovative screening The leading fragment screening platform with MicroScale Thermophoresis at its core Domainex expertise High quality results

More information

Regulatory use of (Q)SARs under REACH

Regulatory use of (Q)SARs under REACH Regulatory use of (Q)SARs under REACH Webinar on Information requirements 10 December 2009 http://echa.europa.eu 1 Using (Q)SAR models Application under REACH to fulfill information requirements Use of

More information

Structure-Based Drug Discovery An Overview

Structure-Based Drug Discovery An Overview Structure-Based Drug Discovery An Overview Edited by Roderick E. Hubbard University of York, Heslington, York, UK and Vernalis (R&D) Ltd, Abington, Cambridge, UK RSC Publishing Contents Chapter 1 3D Structure

More information

Identifying Promising Compounds in Drug Discovery: Genetic Algorithms and Some New Statistical Techniques

Identifying Promising Compounds in Drug Discovery: Genetic Algorithms and Some New Statistical Techniques J. Chem. Inf. Model. 2007, 47, 981-988 981 Identifying Promising Compounds in Drug Discovery: Genetic Algorithms and Some New Statistical Techniques Abhyuday Mandal* Department of Statistics, University

More information

Introduction to Statistical Analysis using IBM SPSS Statistics (v24)

Introduction to Statistical Analysis using IBM SPSS Statistics (v24) to Statistical Analysis using IBM SPSS Statistics (v24) to Statistical Analysis Using IBM SPSS Statistics is a two day instructor-led classroom course that provides an application-oriented introduction

More information

A Picture Paints a Thousand Words Visualisation of SAR. John Cumming, AstraZeneca, Alderley Park, UK

A Picture Paints a Thousand Words Visualisation of SAR. John Cumming, AstraZeneca, Alderley Park, UK A Picture Paints a Thousand Words Visualisation of AR John Cumming, AstraZeneca, Alderley Park, UK Outline Why visualisation? Multi-parameter visualisation tructure fragmentation Matched pair analysis

More information

OECD QSAR Toolbox v.4.1. Tutorial on how to predict Skin sensitization potential taking into account alert performance

OECD QSAR Toolbox v.4.1. Tutorial on how to predict Skin sensitization potential taking into account alert performance OECD QSAR Toolbox v.4.1 Tutorial on how to predict Skin sensitization potential taking into account alert performance Outlook Background Objectives Specific Aims Read across and analogue approach The exercise

More information

Structure-Activity Modeling - QSAR. Uwe Koch

Structure-Activity Modeling - QSAR. Uwe Koch Structure-Activity Modeling - QSAR Uwe Koch QSAR Assumption: QSAR attempts to quantify the relationship between activity and molecular strcucture by correlating descriptors with properties Biological activity

More information

Hydrogen Bonding & Molecular Design Peter

Hydrogen Bonding & Molecular Design Peter Hydrogen Bonding & Molecular Design Peter Kenny(pwk.pub.2008@gmail.com) Hydrogen Bonding in Drug Discovery & Development Interactions between drug and water molecules (Solubility, distribution, permeability,

More information

Introduction to FBDD Fragment screening methods and library design

Introduction to FBDD Fragment screening methods and library design Introduction to FBDD Fragment screening methods and library design Samantha Hughes, PhD Fragments 2013 RSC BMCS Workshop 3 rd March 2013 Copyright 2013 Galapagos NV Why fragment screening methods? Guess

More information

LIFE Project Acronym and Number ANTARES LIFE08 ENV/IT/ Deliverable Report. Deliverable Name and Number

LIFE Project Acronym and Number ANTARES LIFE08 ENV/IT/ Deliverable Report. Deliverable Name and Number LIFE Project Acronym and Number ANTARES LIFE08 ENV/IT/000435 Deliverable Report Deliverable Name and Number Deliverable 2 Report on the identified criteria for non-testing methods, and their scores Deliverable

More information

(e.g.training and prediction set, algorithm, ecc...). 2.9.Availability of another QMRF for exactly the same model: No other information available

(e.g.training and prediction set, algorithm, ecc...). 2.9.Availability of another QMRF for exactly the same model: No other information available QMRF identifier (JRC Inventory):To be entered by JRC QMRF Title: Insubria QSAR PaDEL-Descriptor model for prediction of NitroPAH mutagenicity. Printing Date:Jan 20, 2014 1.QSAR identifier 1.1.QSAR identifier

More information

Automated Stability Testing Delivering Rapid Product Development

Automated Stability Testing Delivering Rapid Product Development Automated Stability Testing Delivering Rapid Product Development Dr Andy Brookes, AstraZeneca APS PharmSci 2-4 th September 2013 With thanks to: Pam Harrison, Helen Porter, Faye Turner, Arun Kamath The

More information

TRAINING REAXYS MEDICINAL CHEMISTRY

TRAINING REAXYS MEDICINAL CHEMISTRY TRAINING REAXYS MEDICINAL CHEMISTRY 1 SITUATION: DRUG DISCOVERY Knowledge survey Therapeutic target Known ligands Generate chemistry ideas Chemistry Check chemical feasibility ELN DBs In-house Analyze

More information

Advanced analysis and modelling tools for spatial environmental data. Case study: indoor radon data in Switzerland

Advanced analysis and modelling tools for spatial environmental data. Case study: indoor radon data in Switzerland EnviroInfo 2004 (Geneva) Sh@ring EnviroInfo 2004 Advanced analysis and modelling tools for spatial environmental data. Case study: indoor radon data in Switzerland Mikhail Kanevski 1, Michel Maignan 1

More information

October 6 University Faculty of pharmacy Computer Aided Drug Design Unit

October 6 University Faculty of pharmacy Computer Aided Drug Design Unit October 6 University Faculty of pharmacy Computer Aided Drug Design Unit CADD@O6U.edu.eg CADD Computer-Aided Drug Design Unit The development of new drugs is no longer a process of trial and error or strokes

More information

Navigation in Chemical Space Towards Biological Activity. Peter Ertl Novartis Institutes for BioMedical Research Basel, Switzerland

Navigation in Chemical Space Towards Biological Activity. Peter Ertl Novartis Institutes for BioMedical Research Basel, Switzerland Navigation in Chemical Space Towards Biological Activity Peter Ertl Novartis Institutes for BioMedical Research Basel, Switzerland Data Explosion in Chemistry CAS 65 million molecules CCDC 600 000 structures

More information

Exploring the black box: structural and functional interpretation of QSAR models.

Exploring the black box: structural and functional interpretation of QSAR models. EMBL-EBI Industry workshop: In Silico ADMET prediction 4-5 December 2014, Hinxton, UK Exploring the black box: structural and functional interpretation of QSAR models. (Automatic exploration of datasets

More information

Chemoinformatics and information management. Peter Willett, University of Sheffield, UK

Chemoinformatics and information management. Peter Willett, University of Sheffield, UK Chemoinformatics and information management Peter Willett, University of Sheffield, UK verview What is chemoinformatics and why is it necessary Managing structural information Typical facilities in chemoinformatics

More information

Analyzing Molecular Conformations Using the Cambridge Structural Database. Jason Cole Cambridge Crystallographic Data Centre

Analyzing Molecular Conformations Using the Cambridge Structural Database. Jason Cole Cambridge Crystallographic Data Centre Analyzing Molecular Conformations Using the Cambridge Structural Database Jason Cole Cambridge Crystallographic Data Centre 1 The Cambridge Structural Database (CSD) 905,284* USOPEZ a natural product intermediate,

More information

Gaussian Processes: We demand rigorously defined areas of uncertainty and doubt

Gaussian Processes: We demand rigorously defined areas of uncertainty and doubt Gaussian Processes: We demand rigorously defined areas of uncertainty and doubt ACS Spring National Meeting. COMP, March 16 th 2016 Matthew Segall, Peter Hunt, Ed Champness matt.segall@optibrium.com Optibrium,

More information

Synthetic organic compounds

Synthetic organic compounds Synthetic organic compounds for research and drug discovery chemicals Compounds for TS Fragment libraries Target-focused libraries Chemical building blocks Custom synthesis Drug discovery services Contract

More information

OECD QSAR Toolbox v.3.2. Step-by-step example of how to build and evaluate a category based on mechanism of action with protein and DNA binding

OECD QSAR Toolbox v.3.2. Step-by-step example of how to build and evaluate a category based on mechanism of action with protein and DNA binding OECD QSAR Toolbox v.3.2 Step-by-step example of how to build and evaluate a category based on mechanism of action with protein and DNA binding Outlook Background Objectives Specific Aims The exercise Workflow

More information

Protein structure based approaches to inhibit Plasmodium DHODH for malaria

Protein structure based approaches to inhibit Plasmodium DHODH for malaria Protein structure based approaches to inhibit Plasmodium DHDH for malaria Peter Johnson University of Leeds, School of Chemistry email p.johnson@leeds.ac.uk Tools for protein structure based approaches

More information

Kernel-based Machine Learning for Virtual Screening

Kernel-based Machine Learning for Virtual Screening Kernel-based Machine Learning for Virtual Screening Dipl.-Inf. Matthias Rupp Beilstein Endowed Chair for Chemoinformatics Johann Wolfgang Goethe-University Frankfurt am Main, Germany 2008-04-11, Helmholtz

More information

An automated synthesis programme for drug discovery

An automated synthesis programme for drug discovery An automated synthesis programme for drug discovery Automation has revolutionised the way that organic synthesis is performed in the research laboratory. Dr James Harness, Bohdan Automation Inc Combinatorial

More information

Drug Design 2. Oliver Kohlbacher. Winter 2009/ QSAR Part 4: Selected Chapters

Drug Design 2. Oliver Kohlbacher. Winter 2009/ QSAR Part 4: Selected Chapters Drug Design 2 Oliver Kohlbacher Winter 2009/2010 11. QSAR Part 4: Selected Chapters Abt. Simulation biologischer Systeme WSI/ZBIT, Eberhard-Karls-Universität Tübingen Overview GRIND GRid-INDependent Descriptors

More information

Dynamic Combinatorial Chemistry in the identification of new host guest interactions: proof of principle

Dynamic Combinatorial Chemistry in the identification of new host guest interactions: proof of principle Dynamic Combinatorial Chemistry in the identification of new host guest interactions: proof of principle ick Paras MacMillan Group Meeting ctober 17, 2001 Lead References: Lehn, J.-M.; Eliseev, A. V. Science

More information

OECD QSAR Toolbox v.4.1

OECD QSAR Toolbox v.4.1 OECD QSAR Toolbox v.4.1 Step-by-step example on how to predict the skin sensitisation potential approach of a chemical by read-across based on an analogue approach Outlook Background Objectives Specific

More information

New Synthetic Technologies in Medicinal Chemistry

New Synthetic Technologies in Medicinal Chemistry New Synthetic Technologies in Medicinal Chemistry Edited by Elizabeth Farrant Worldwide Medicinal Chemistry, Pfizer Ltd., Sandwich, Kent, UK Chapter 1 Chapter 2 Introduction Elizabeth Farrant 1.1 Introduction

More information

Project I. Heterocyclic and medicinal chemistry

Project I. Heterocyclic and medicinal chemistry Thesis projecten 2018-2019 onderzoeksgroep LOSA professor Wim Dehaen Project I. Heterocyclic and medicinal chemistry - Novel products with interesting biological properties In this line of research, novel

More information